Autologous Cell Therapy Market Poised $2.2 Billion by 2017


Posted January 23, 2014 by marketreport

Autologous Stem Cell & Non-stem Cell Therapy Market report includes applications of the technology and trends in terms of ACT market size and growth of autologous cellular therapies in medical treatments globally

 
The report “Autologous Cell Therapy (ACT) Market (2012 - 2017)”, would be the first global and exclusive report on ACT market. It also gives clear information about the complete industry, approved products and potential market size; it also identifies driving and restraining factors for the global ACT market with analysis of trends, opportunities and challenges. The market is segmented and revenue is forecasted on the basis of major regions such as USA, Europe and Rest of the World (ROW). Further, market is segmented and revenues are forecasted on the basis of potential application areas of ACT.

Browse ACT market research data tables/figures spread through 111 slides and in-depth TOC on “Autologous Cell Therapy (ACT) Market"
http://www.marketsandmarkets.com/Market-Reports/autologous-cell-therapy-market-837.html
Autologous Stem Cell and Non-Stem Cell Based Therapies market is currently estimated as $650 million, including products of all application areas. This market is anticipated to reach $2.2 billion by 2017, growing at a CAGR of 21%. Several products and technologies of ACT are in pipeline which is expected to hit the market during the forecast period, which will result in increased growth rate.
Investment activities, for past five years are actively held in research and developments, attracting interests of cell therapy industry firms, medical centers and academic institutions. ACT potential can be demonstrated by mergers, collaborations, acquisitions and partnerships that happened actively between the ACT technology developing companies in past three years. Development of sophisticated automation devices for cell expansion and culture process for use in the treatment is one of the emerging trends of ACT market.
About MarketsandMarkets

MarketsandMarkets (M&M) is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services.
M&M covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. To know more about us and our reports, please visit our website www.marketsandmarkets.com
Contact:
Mr. Rohan
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Tel: +1-888-6006-441
Email: [email protected]
http://www.marketsandmarkets.com
http://marketsandmarkets.blogspot.com/
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By marketsandmarkets
Website http://www.marketsandmarkets.com/Market-Reports/autologous-cell-therapy-market-837.html
Phone +1-888-6006-441
Business Address North - Dominion Plaza 17304 Preston Road
Suite 800, Dallas, TX 75252
Country United States
Categories Health , Reports , Research
Tags act market , autologous stem cell market , autologous stem cell transplant , stem cell therapy market
Last Updated January 23, 2014